SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 110.60 |
| Enterprise Value ($M) | 62.95 |
| Book Value ($M) | 212.68 |
| Book Value / Share | 4.13 |
| Price / Book | 0.52 |
| NCAV ($M) | 178.26 |
| NCAV / Share | 3.47 |
| Price / NCAV | 0.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.79 |
| Current Ratio | 16.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 202.46 |
| Assets | 236.88 |
| Liabilities | 24.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -80.13 |
| Net Income | -68.96 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -55.66 |
| Cash from Investing | -50.55 |
| Cash from Financing | 35.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Jpmorgan Chase & Co | 0.00 | -99.58 | |
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G | ArrowMark Colorado Holdings LLC | 5.31 | ||
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
| 13G/A | Citadel Advisors Llc | 2.40 | ||
| 13G/A | Boxer Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 4.70 | -12.65 | |
| 13G/A | BlackRock Inc. | 6.30 | -30.94 | |
| 13G/A | State Street Corp | 1.41 | 11.89 | |
| 13D/A | Orbimed Advisors Llc | 13.50 | -0.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 32,908 | 62,545 | 52.61 | |
| 38,631 | 186,483 | 20.72 | |
| 38,692 | 398,569 | 9.71 | |
| 45,637 | 330,847 | 13.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PHAT – Phathom Pharmaceuticals, Inc. | PHVS – Pharvaris N.V. |
| PLRX – Pliant Therapeutics, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated |
Financial data and stock pages provided by
Fintel.io